Somatically derived ovarian yolk sac tumor in a postmenopausal woman: A case report of durable remission with personalized chemotherapy
This case underscores the potential for long-term remission in SD-YST with platinum-based therapy, even when standard regimens require modification for older or frail patients. It highlights the value of biomarker-guided treatment adjustments to optimize chemotherapy timing in rare ovarian malignancies.
Authors
- Vinita Popat (ORCID: https://orcid.org/0000-0003-2837-842X)
- A. Justin Rucker (ORCID: https://orcid.org/0000-0001-7538-1838)
- Joseph W. Carlson (ORCID: https://orcid.org/0000-0002-3006-4107)
- Lorna Rodriguez-Rodriguez
- Aimee Keegan
Institutions
- City Of Hope National Medical Center (US)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1016/j.gore.2025.101989
- Primary Topic
- Testicular diseases and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00